Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 09:28 am Sale | 2024-12-31 | 13G | Cytokinetics, Incorporated CYTK | FMR LLC | 11,146,954 9.400% | -1,268,688 (-10.22%) | Filing History |
| 2025-01-08 11:29 am Purchase | 2024-12-31 | 13G | Cytokinetics, Incorporated CYTK | VANGUARD GROUP INC | 11,915,821 10.090% | 154,216 (+1.31%) | Filing History |
| 2024-11-14 1:28 pm Purchase | 2024-09-30 | 13G | Cytokinetics, Incorporated CYTK | T. Rowe Price Investment Management Inc. | 9,689,987 8.200% | 9,689,987 (New Position) | Filing History |
| 2024-11-12 2:21 pm Unchanged | 2024-09-30 | 13G | Cytokinetics, Incorporated CYTK | VANGUARD GROUP INC | 11,761,605 9.990% | 0 (Unchanged) | Filing History |
| 2024-11-12 11:44 am Unchanged | 2024-09-30 | 13G | Cytokinetics, Incorporated CYTK | BlackRock Inc. BLK | 15,252,905 13.000% | 0 (Unchanged) | Filing History |
| 2024-11-12 09:55 am Sale | 2024-11-08 | 13G | Cytokinetics, Incorporated CYTK | FMR LLC | 12,415,642 10.518% | -592,141 (-4.55%) | Filing History |
| 2024-11-04 11:17 am Purchase | 2024-09-30 | 13G | Cytokinetics, Incorporated CYTK | VANGUARD GROUP INC | 11,761,605 9.990% | 744,716 (+6.76%) | Filing History |
| 2024-10-23 5:04 pm Sale | 2024-09-30 | 13G | Cytokinetics, Incorporated CYTK | BlackRock Inc. BLK | 15,252,905 13.000% | -1,047,636 (-6.43%) | Filing History |
| 2024-02-13 5:02 pm Purchase | 2023-12-29 | 13G | Cytokinetics, Incorporated CYTK | VANGUARD GROUP INC | 11,016,889 11.240% | 943,795 (+9.37%) | Filing History |
| 2024-02-09 08:50 am Sale | 2024-02-08 | 13G | Cytokinetics, Incorporated CYTK | FMR LLC | 13,007,783 13.265% | -401,460 (-2.99%) | Filing History |
| 2024-02-08 10:11 am Sale | 2023-12-29 | 13G | Cytokinetics, Incorporated CYTK | WELLINGTON MANAGEMENT GROUP LLP | 6,530,884 6.660% | -11,840 (-0.18%) | Filing History |
| 2024-01-25 10:45 am Purchase | 2023-12-31 | 13G | Cytokinetics, Incorporated CYTK | STATE STREET CORP STT | 5,893,358 6.010% | 848,444 (+16.82%) | Filing History |
| 2024-01-22 2:03 pm Purchase | 2023-12-31 | 13G | Cytokinetics, Incorporated CYTK | BlackRock Inc. BLK | 16,300,541 16.400% | 532,667 (+3.38%) | Filing History |
| 2023-02-10 2:11 pm Unchanged | 2022-12-31 | 13G | Cytokinetics, Incorporated CYTK | BlackRock Inc. BLK | 15,767,874 16.700% | 0 (Unchanged) | Filing History |
| 2023-02-09 11:16 am Purchase | 2022-12-30 | 13G | Cytokinetics, Incorporated CYTK | VANGUARD GROUP INC | 10,073,094 10.640% | 1,331,970 (+15.24%) | Filing History |
| 2023-02-09 09:59 am Purchase | 2023-02-09 | 13G | Cytokinetics, Incorporated CYTK | FMR LLC | 13,409,243 14.162% | 819,408 (+6.51%) | Filing History |
| 2023-02-06 2:51 pm Purchase | 2022-12-30 | 13G | Cytokinetics, Incorporated CYTK | WELLINGTON MANAGEMENT GROUP LLP | 6,542,724 6.910% | 6,542,724 (New Position) | Filing History |
| 2023-02-03 09:51 am Purchase | 2022-12-31 | 13G | Cytokinetics, Incorporated CYTK | STATE STREET CORP STT | 5,044,914 5.330% | 1,059,687 (+26.59%) | Filing History |
| 2023-01-26 08:52 am Purchase | 2022-12-31 | 13G | Cytokinetics, Incorporated CYTK | BlackRock Inc. BLK | 15,767,874 16.000% | 800,557 (+5.35%) | Filing History |
| 2023-01-20 3:00 pm Purchase | 2022-12-31 | 13G | Cytokinetics, Incorporated CYTK | BlackRock Inc. BLK | 14,967,317 16.000% | 2,016,353 (+15.57%) | Filing History |